Clinical observations and animal studies showed the critical role of C3a in supporting tumor growth: C3 (and C3a cleavage product) produced by CD8 + T cells may promote tumor progression by inhibiting these cells’ IL-10 production [27]. The gene discussed is CD8A; the disease is neoplasm.